Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial

INTRODUCTION: Optimal adjustment of basal insulin to overcome hypoglycemia and glycemic variability (GV) depends on its duration of action and peak-less profile. Owing to the ability of long-acting basal insulin to avoid hypoglycemia, we titrated pre-meal glucose to normal fasting blood glucose, 80–...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Iga, Ryo, Uchino, Hiroshi, Kanazawa, Ken, Usui, Shuki, Miyagi, Masahiko, Kumashiro, Naoki, Yoshino, Hiroshi, Ando, Yasuyo, Hirose, Takahisa
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544606/
https://ncbi.nlm.nih.gov/pubmed/28547206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0269-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars